Bing Xu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Diffuse Large B Cell Lymphoma

Machine Learning

Acute Myeloid Leukemia

Top Venues

American journal of hematology

Stem cell reviews and reports

Cellular & molecular immunology

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Jian Tang, Xian Jia, Jian Li, Junchen Dong, Jiayu Wang, Wanyun Li, Yuzhen Zhu, Yanyan Hu, Bowen Hou, Chunjie Lin, Yu Cong, Tong Ren, Changsheng Yan, Hongying Yang, Qian Lai, Haiping Zheng, Yuzhou Bao, Namrata Gautam, Hong-Rui Wang, Bing Xu, Xiao Lei Chen, Qing Li, Nicholas R J Gascoigne, Guo Fu
Themis suppresses the effector function of CD8 + T cells in acute viral infection. Cellular & molecular immunology (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Maher Albitar, Hong Zhang, Andre H Goy, Zijun Y Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D Hsi, Fredrick B Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés José Maria Ferreri, Michael Boe Møller, Benjamin M Parsons, J Han van Krieken, Miguel A Piris, Jane N Winter, Yong Li, Bing Xu, Ken H H Young
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms. Blood cancer journal 12 (2) (2022)
Liying Feng, Kai Chen, Wei Huang, Yuelong Jiang, Xihuan Sun, Yong Zhou, Li Li, Yin Li, Xianming Deng, Bing Xu
Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma. Cell death discovery 8 (1) (2022)
Yongchao Liu, Yu Cong, Yujia Niu, Yin Yuan, Fancheng Tan, Qian Lai, Yanyan Hu, Bowen Hou, Jian Li, Chunjie Lin, Haiping Zheng, Junchen Dong, Jian Tang, Qinwei Chen, Joanna Brzostek, Xueqin Zhang, Xiao Lei Chen, Hong-Rui Wang, Nicholas R J Gascoigne, Bing Xu, Shu-Hai Lin, Guo Fu
Themis is indispensable for IL-2 and IL-15 signaling in T cells. Science signaling 15 (721) (2022)
Xiao-Dong Mo, Shen-Da Hong, Yan-Li Zhao, Er-Lie Jiang, Jing Chen, Yang Xu, Zi-Min Sun, Wei-Jie Zhang, Qi-Fa Liu, Dai-Hong Liu, Ding-Ming Wan, Wen-Jian Mo, Han-Yun Ren, Ting Yang, He Huang, Xi Zhang, Xiao-Ning Wang, Xian-Min Song, Su-Jun Gao, Xin Wang, Yi Chen, Bing Xu, Ming Jiang, Xiao-Bing Huang, Xin Li, Hong-Yu Zhang, Hong-Tao Wang, Zhao Wang, Ting Niu, Ji-Shi Wang, Ling-Hui Xia, Xiao-Dan Liu, Fei Li, Fang Zhou, Tao Lang, Jiong Hu, Sui-Jing Wu, Xiao-Jun Huang
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis. American journal of hematology 97 (4) (2022)
Jie Zha, Qian Lai, Manman Deng, Pengcheng Shi, Haijun Zhao, Qinwei Chen, Hua Wu, Bing Xu
Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia. Stem cell reviews and reports 16 (6) (2020)
Pengcheng Shi, Jie Zha, Juan Feng, Zhiwu Jiang, Haijun Zhao, Manman Deng, Naying Liao, Peng Li, Yirong Jiang, Haihan Song, Bing Xu
Low-Dose Triptolide Enhanced Activity of Idarubicin Against Acute Myeloid Leukemia Stem-like Cells Via Inhibiting DNA Damage Repair Response. Stem cell reviews and reports 17 (2) (2020)
Jing Ye, Jie Zha, Yuanfei Shi, Yin Li, Delin Yuan, Qinwei Chen, Fusheng Lin, Zhihong Fang, Yong Yu, Yun Dai, Bing Xu
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Clinical epigenetics 11 (1) (2019)
Leisi Zhang, Yong Zhou, Kai Chen, Pengcheng Shi, Yin Li, Manman Deng, Zhiwu Jiang, Xiangmeng Wang, Peng Li, Bing Xu
The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells. Targeted oncology 12 (5) (2018)